India Globalization Capital, Inc.
General ticker "IGC" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $27.3M (TTM average)
India Globalization Capital, Inc. follows the US Stock Market performance with the rate: 43.5%.
Estimated limits based on current volatility of 2.6%: low 0.30$, high 0.32$
Factors to consider:
- Total employees count: 67 (+9.8%) as of 2024
- US accounted for 87.7% of revenue in the fiscal year ended 2024-03-31
- Top business risk factors: Accumulated deficit, Dependence on resellers, Strategic risks and growth management, Geopolitical risks, Inability to forecast demand
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [0.20$, 0.52$]
- 2026-03-31 to 2027-03-31 estimated range: [0.19$, 0.50$]
Financial Metrics affecting the IGC estimates:
- Positive: with PPE of -3.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -20.47 <= 0.33
- Positive: Inventory ratio change, % of -2.34 <= -0.75
- Positive: Shareholder equity ratio, % of 72.37 > 63.39
- Positive: -4.48 < Investing cash flow per share per price, % of -1.89
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Industry operating cash flow (median)
Short-term IGC quotes
Long-term IGC plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $0.91MM | $1.34MM | $1.27MM |
| Operating Expenses | $12.48MM | $11.14MM | $8.72MM |
| Operating Income | $-11.57MM | $-9.80MM | $-7.45MM |
| Non-Operating Income | $0.07MM | $-3.20MM | $0.33MM |
| R&D Expense | $3.46MM | $3.77MM | $3.65MM |
| Income(Loss) | $-11.51MM | $-13.00MM | $-7.12MM |
| Profit(Loss)* | $-11.51MM | $-13.00MM | $-7.12MM |
| Stockholders Equity | $14.91MM | $7.32MM | $6.33MM |
| Inventory | $2.65MM | $1.58MM | $1.36MM |
| Assets | $17.18MM | $9.90MM | $8.75MM |
| Operating Cash Flow | $-7.05MM | $-5.20MM | $-4.79MM |
| Capital expenditure | $0.62MM | $0.52MM | $0.48MM |
| Investing Cash Flow | $-0.23MM | $-0.32MM | $-0.44MM |
| Financing Cash Flow | $0.10MM | $3.52MM | $4.45MM |
| Earnings Per Share** | $-0.22 | $-0.22 | $-0.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.